ArticleInternal and emergency medicine2026

Prescription of SGLT-2 inhibitors alone or in combination with RAS-inhibitors in patients with diabetes mellitus and comorbid cardiovascular disease, chronic kidney disease or cardiorenal disease: a real-world evidence study from the REPOSI registry.

Paolo Lido et al.PubMed ↗Publisher ↗

No numbers read from the abstract.